Cargando…

Metabolic Alterations, Aggressive Hormone-Naïve Prostate Cancer and Cardiovascular Disease: A Complex Relationship

Background: Epidemiological studies suggest a possible relationship between metabolic alterations, cardiovascular disease and aggressive prostate cancer, however, no clear consensus has been reached. Objective: The aim of the study was to analyze the recent literature and summarize our experience on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Francesco, Simona, Robuffo, Iole, Caruso, Marika, Giambuzzi, Giulia, Ferri, Deborah, Militello, Andrea, Toniato, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473682/ https://www.ncbi.nlm.nih.gov/pubmed/30866568 http://dx.doi.org/10.3390/medicina55030062

Ejemplares similares

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
por: Di Gregorio, Jacopo, et al.
Publicado: (2020)

Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis
por: Di Francesco, Simona, et al.
Publicado: (2013)

Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line
por: Avolio, Francesco, et al.
Publicado: (2022)

Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression
por: Spalletta, Sonia, et al.
Publicado: (2018)

Morphological and functional alterations of the prostate tissue during clinical progression in hormonally-naïve, hormonally-treated and castration-resistant patients with metastatic prostate cancer
por: Korček, Michal, et al.
Publicado: (2020)

Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
por: Recine, Federica, et al.
Publicado: (2015)

Hormone naïve prostate cancer: predicting and maximizing response intervals
por: Moul, Judd W
Publicado: (2015)

Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer Patients
por: Russo, Giorgio Ivan, et al.
Publicado: (2022)

Critical evaluation of the subcutaneous engraftments of hormone naïve primary prostate cancer
por: Valta, Maija, et al.
Publicado: (2020)

Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapy
por: Pham, Thy, et al.
Publicado: (2016)

Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells
por: Cacciatore, Ivana, et al.
Publicado: (2023)

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
por: Merson, S, et al.
Publicado: (2014)

Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer
por: Yoshikawa, Yuki, et al.
Publicado: (2022)

Phase II Clinical Trial of GM-CSF Treatment in Patients with Hormone-Refractory or Hormone-Naïve Adenocarcinoma of the Prostate
por: Amato, Robert J., et al.
Publicado: (2008)

Taxane Chemotherapy for Hormone-Naïve Prostate Cancer with Its Expanding Role as Breakthrough Strategy
por: Shiota, Masaki, et al.
Publicado: (2016)

Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases
por: Schmidt, Linnéa, et al.
Publicado: (2018)

Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer
por: Roy, Soumyajit, et al.
Publicado: (2023)

Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness
por: Robles-Fernandez, Inmaculada, et al.
Publicado: (2017)

Cardiovascular effects of hormone therapy for prostate cancer
por: Lester, Jason F, et al.
Publicado: (2015)

Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods
por: Moyad, Mark A
Publicado: (2015)

Aggressive behavior in psychiatric patients in relation to hormonal imbalance (Review)
por: Trifu, Simona Corina, et al.
Publicado: (2020)

Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer
por: Armstrong, K, et al.
Publicado: (2011)

Rationale for Stereotactic Body Radiation Therapy in Treating Patients with Oligometastatic Hormone-Naïve Prostate Cancer
por: Bhattasali, Onita, et al.
Publicado: (2013)

TRPM8 protein expression in hormone naïve local and lymph node metastatic prostate cancer
por: Lunardi, Andrea, et al.
Publicado: (2021)

Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy
por: Smentoch, Julia, et al.
Publicado: (2019)

Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer
por: Suzuki, Hiroyoshi, et al.
Publicado: (2019)

Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

Addressing Cardiovascular Risk of Prostate Cancer Hormonal Therapy
por: Ryan, Charles J., et al.
Publicado: (2020)

Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells
por: Paxson, Allan I., et al.
Publicado: (2023)

The Importance of Time to Prostate-Specific Antigen (PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients
por: Sasaki, Takeshi, et al.
Publicado: (2018)

Establishment and characterization of prostate organoids from treatment-naïve patients with prostate cancer
por: Cheaito, Katia, et al.
Publicado: (2022)

Autoantibodies reactive to adrenocorticotropic hormone can alter cortisol secretion in both aggressive and nonaggressive humans
por: Værøy, Henning, et al.
Publicado: (2018)

Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2012)

AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy
por: Winther, Mads Dochedahl, et al.
Publicado: (2020)

A novel prognostic model for Japanese patients with newly diagnosed bone‐metastatic hormone‐naïve prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

A lower psoas muscle index predicts a poorer prognosis in metastatic hormone‐naïve prostate cancer
por: Iwamoto, Genta, et al.
Publicado: (2020)

Aggression in Women: Behavior, Brain and Hormones
por: Denson, Thomas F., et al.
Publicado: (2018)

Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis
por: Mishra, Prachi, et al.
Publicado: (2019)

Cardiovascular risk during hormonal treatment in patients with prostate cancer
por: Van Poppel, Hein, et al.
Publicado: (2011)

Relationship Between Thyroid-Stimulating Hormone Level and Aggressive Pathological Features of Papillary Thyroid Cancer
por: Demircioglu, Zeynep Gul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qck2tjdl48kr6lg7ajrkmlc7od